Literature DB >> 20661084

Polymorphisms in the caspase genes and the risk of lung cancer.

Shin Yup Lee1, Yi Young Choi, Jin Eun Choi, Min Jung Kim, Jong-Sik Kim, Deuk Kju Jung, Hyo-Gyoung Kang, Hyo-Sung Jeon, Won Kee Lee, Guang Jin, Seung Ick Cha, Chang Ho Kim, Tae Hoon Jung, Jae Yong Park.   

Abstract

INTRODUCTION: Caspases (CASPs) are important regulators and executioners in apoptosis pathway and play a crucial role in the development and progression of cancer. On the basis of the interactions of CASPs in the apoptotic pathway, we evaluated the association between 11 polymorphisms of CASP3, 6, 7, 8, 9, and 10 genes and the risk of lung cancer.
METHODS: The genotypes were determined in 720 patients with lung cancer and 720 healthy controls frequency matched for age and gender.
RESULTS: In individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively. In the case of the CASP3 77G>A, subjects with the GG genotype were at a 1.19-fold increased risk of lung cancer compared with those with at least one variant allele. When the three polymorphisms were combined, the risk of lung cancer increased in a dose-dependent manner as the number of risk genotypes increased (ptrend <0.001). Subjects with two and three risk genotypes carried a significantly increased risk of lung cancer compared with those with zero risk genotype (adjusted odds ratio = 1.56, 95% confidence interval = 1.14-2.13, p = 0.005 and adjusted odds ratio = 2.54, 95% confidence interval = 1.28-5.02, p = 0.008, respectively).
CONCLUSIONS: These results suggest that a combined analysis of these three CASP gene polymorphisms might better predict the risk of lung cancer than analysis of a single polymorphism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661084     DOI: 10.1097/JTO.0b013e3181e04543

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Authors:  Jie Lin; Charles Lu; David J Stewart; Jian Gu; Maosheng Huang; David W Chang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

Review 2.  Genetic determinants of neuronal vulnerability to apoptosis.

Authors:  Angeles Almeida
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

3.  Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.

Authors:  Saman Sargazi; Armin Zahedi Abghari; Hosna Sarani; Roghayeh Sheervalilou; Shekoufeh Mirinejad; Ramin Saravani; Ebrahim Eskandari
Journal:  Appl Biochem Biotechnol       Date:  2021-08-31       Impact factor: 2.926

4.  Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.

Authors:  Ji Qian; Hui-Qi Qu; Lixin Yang; Ming Yin; Qiming Wang; Shaohua Gu; Qihan Wu; Xueying Zhao; Wenting Wu; Junjie Wu; Xiaoming Tan; Wenqing Chen; Haijian Wang; Jiucun Wang; Weiwei Fan; Hongyan Chen; Baohui Han; Daru Lu; Qingyi Wei; Li Jin
Journal:  Oncologist       Date:  2012-07-27

5.  Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.

Authors:  Anuradha Cingeetham; Sugunakar Vuree; Nageswara Rao Dunna; Manjula Gorre; Santhoshi Rani Nanchari; Prajitha Mohandas Edathara; Phannibhusan Mekkaw; Sandhya Annamaneni; Raghunadha Rao Digumarthi; Sudha Sinha; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2014-05-31

Review 6.  Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.

Authors:  Maria I Avrutsky; Carol M Troy
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.988

7.  A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility.

Authors:  Wei Xu; Shengqiang Jiang; Yuanyuan Xu; Bo Chen; Yan Li; Feng Zong; Weihong Zhao; Jianqing Wu
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

8.  Association Study of the Caspase Gene Family and Psoriasis Vulgaris Susceptibility in Northeastern China.

Authors:  Xinyu Yao; Siyu Hao; Pei Yu
Journal:  Biomed Res Int       Date:  2019-02-17       Impact factor: 3.411

9.  Role of CASP7 polymorphisms in noise-induced hearing loss risk in Han Chinese population.

Authors:  Yanmei Ruan; Jinwei Zhang; Shiqi Mai; Wenfeng Zeng; Lili Huang; Chunrong Gu; Keping Liu; Yuying Ma; Zhi Wang
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.